# Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

> **NCT01349777** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 1056 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Pregrel®
- **DRUG:** Plavix®

## Key facts

- **NCT ID:** NCT01349777
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-15
- **Primary completion:** 2017-03-14
- **Final completion:** 2017-03-14
- **Target enrollment:** 1056 (ACTUAL)
- **Last updated:** 2017-06-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01349777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01349777, "Effectiveness of Clopidogrel Resinate in PCI(PRIDE)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01349777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*